South Korea’s health insurance system, a social safety net designed to alleviate medical costs, has evolved since its inception in 1977, achieving universal coverage by 1989. Over the years, the system has expanded to cover hospital ward fees, MRIs, and ultrasounds. However, concerns over rising fiscal pressure and fairness have persisted. The latest debate centers on whether health insurance should cover hair loss treatments.
During a Health and Welfare Ministry briefing, President Lee Jae-myung described hair loss as “a matter of survival” and called for a review of expanding insurance coverage to include treatments for the condition. Following the president’s directive, the Ministry of Health and Welfare announced on the 22nd that it had begun a comprehensive review to explore support measures, particularly for young people who have consistently paid premiums.
A ministry official explained, “Alongside reviewing expanded reimbursement for hair loss treatment, we also plan to examine ways to reduce health insurance spending, such as adjusting compensation for mild conditions and curbing overuse of medical services.”
Rising Concerns Over Fiscal Impact
Medical experts, however, have voiced concerns about the proposal. Critics argue that reimbursing hair loss could substantially increase the fiscal burden and undermine the principle that public health insurance prioritizes serious illnesses and essential treatments. Patients with cancer and rare diseases, still waiting for reimbursement of costly new drugs, have also questioned the fairness of prioritizing hair loss.
Currently, insurance only covers hair loss linked to medical conditions like alopecia areata or seborrheic dermatitis. Hair loss due to genetic factors or aging is considered cosmetic and remains non-reimbursed. With an estimated 10 million people experiencing hair loss in Korea, advocates argue that expanding coverage could alleviate the psychological and social burdens young adults face in job hunting and daily life.
However, estimates suggest the cost could be substantial. The Health Insurance Review & Assessment Service (HIRA) reported that medical expenses for alopecia in 2024 totaled nearly 39 billion won. Between 2020 and mid-2025, over 1.1 million patients received alopecia treatment under insurance, with total expenses reaching 191 billion won. The number of patients treated for hair loss in 2024 alone rose to 237,617, a 14% increase from 2015.
According to Kim Jae-yeon, legal director of the Korean Medical Association Organization, “If reimbursement expands to hereditary hair loss, annual fiscal expenditure could increase from 1 trillion to 3.6 trillion won.” Even modest projections estimate that covering one-third of Korea’s hair loss population could cost nearly 1 trillion won annually, accounting only for medication, excluding consultation and tests.
Experts also highlight the ongoing nature of treatment. Hair loss medication, including finasteride, dutasteride, and minoxidil, typically costs 20,000 to 50,000 won per month and requires continuous use to maintain results. As a result, hair loss treatment could become a fixed, long-term expense for health insurance.
Ethical and Policy Concerns
The proposal has sparked broader ethical debates. Critics argue that hair loss, while distressing, is not life-threatening and should not take precedence over serious diseases. Heo Yoon-jung, an intensivist at Dankook University Hospital, stated, “Hair loss does not threaten life or bodily functions. Health insurance should prioritize conditions directly tied to survival.”
Patient groups for rare and incurable diseases also voiced concerns about fairness. An official from the Korea Alliance of Patients with Rare and Incurable Diseases said, “Insurance already covers pathological hair loss. There are many serious diseases, including those affecting infants, that desperately need coverage.”
Critics have also called out what they see as political populism, noting that the debate accelerated after the presidential directive and received public endorsements from government officials without sufficient scrutiny.
Sustainability Challenges
South Korea’s health insurance system is already facing financial strain amid an aging population and low birthrates. Cumulative reserves currently total around 30 trillion won, with projected deficits expected to start next year and reserves potentially exhausted by 2030. Health and Welfare Minister Jung Eun-kyeong acknowledged that reimbursing hair loss would have a “significant impact” on the budget.
Jung Hyung-seon, a Yonsei University health administration professor, emphasized the difficulty of categorizing hair loss as either therapeutic or cosmetic, noting that any expansion of coverage would require careful consideration of funding, copayment rates, and long-term sustainability.
As discussions continue, experts warn that prioritizing hair loss could divert resources from more urgent medical needs, raising questions about the future direction of South Korea’s health insurance policy.
